Ankyrin 1 (ANK1) is associated genetically with Diabetes type 2 (37), spherocytosis (38) and epigenetically with neurological diseases, likely triggered by ApoE with effect on TNFalpha and Akt (39). This evidence concerns the gene APOE and nervous system disorder.